Reuters logo
BRIEF-Resverlogix announces fourth positive recommendation from DSMB
2017年6月28日 / 中午11点30分 / 4 个月前

BRIEF-Resverlogix announces fourth positive recommendation from DSMB

June 28 (Reuters) - Resverlogix Corp

* Resverlogix announces fourth positive recommendation from data safety monitoring board for phase 3 study of apabetalone

* Says ‍dsmb reviewed available study data and noted that no safety or efficacy concerns were identified​

* Resverlogix corp - recommendation confirms that apabetalone continues to be safe and well-tolerated

* Says ‍will conduct additional periodic reviews​

* Says ‍resverlogix, clinical steering committee, and all investigators remain blinded to trial data​

* Resverlogix corp - remain on track for full enrollment by fall of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below